{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:22:47Z","timestamp":1777576967987,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","award":["UL1 TR001082"],"award-info":[{"award-number":["UL1 TR001082"]}],"id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.07.082","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T23:12:27Z","timestamp":1438470747000},"page":"4790-4797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children"],"prefix":"10.1016","volume":"33","author":[{"given":"Donna","family":"Curtis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangeli F.","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Armon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2015.07.082_bib0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.07.082_bib0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.082_bib0175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1086\/502574","article-title":"Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults","volume":"26","author":"Talbot","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.082_bib0180","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2015.07.082_bib0185","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1371\/journal.pone.0002975","article-title":"Influence of prior influenza vaccination on antibody and B-cell responses","volume":"3","author":"Sasaki","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.082_bib0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1750-2659.2010.00183.x","article-title":"The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.082_bib0195","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.vaccine.2011.11.104","article-title":"The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.082_bib0200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.082_bib0205","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.082_bib0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.082_bib0215","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1542\/peds.2006-2836","article-title":"Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children","volume":"120","author":"Piedra","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.082_bib0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1750-2659.2009.00124.x","article-title":"Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age","volume":"4","author":"Belshe","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.082_bib0225","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jpids\/pit040","article-title":"Immunogenicity of licensed influenza A (H1N1) 2009 monovalent vaccines in HIV-infected children and youth","volume":"2","author":"Pass","year":"2013","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.082_bib0230","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/infdis\/jis360","article-title":"Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults","volume":"206","author":"Flynn","year":"2012","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.082_bib0235","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/QAI.0b013e318232b50e","article-title":"Antibody response to inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with and without HIV","volume":"58","author":"Tiu","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"10.1016\/j.vaccine.2015.07.082_bib0240","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.vaccine.2011.01.091","article-title":"Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status","volume":"29","author":"Kosalaraksa","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.082_bib0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAD.0b013e32835ab5b2","article-title":"Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial","volume":"27","author":"Madhi","year":"2013","journal-title":"AIDS"},{"issue":"24","key":"10.1016\/j.vaccine.2015.07.082_bib0250","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1016\/j.vaccine.2011.03.097","article-title":"Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer","volume":"29","author":"Halasa","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.082_bib0255","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/infdis\/jir561","article-title":"Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer","volume":"204","author":"Carr","year":"2011","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2015.07.082_bib0260","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2015.07.082_bib0265","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31806166f8","article-title":"Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia","volume":"26","author":"Tam","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2015.07.082_bib0270","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1542\/peds.2006-0725","article-title":"Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care","volume":"118","author":"Vesikari","year":"2006","journal-title":"Pediatrics"},{"issue":"33","key":"10.1016\/j.vaccine.2015.07.082_bib0275","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.vaccine.2008.05.054","article-title":"Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children","volume":"26","author":"Levin","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.07.082_bib0280","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00006454-200112000-00006","article-title":"Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children","volume":"20","author":"King","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.082_bib0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/QAI.0b013e3181e46308","article-title":"Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children","volume":"55","author":"Weinberg","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.vaccine.2015.07.082_bib0290","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0b013e31825687b0","article-title":"Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children","volume":"31","author":"Block","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.082_bib0295","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/315246","article-title":"Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults","volume":"181","author":"King","year":"2000","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.082_bib0300","doi-asserted-by":"crossref","first-page":"e13755","DOI":"10.1371\/journal.pone.0013755","article-title":"Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials","volume":"5","author":"Mallory","year":"2010","journal-title":"PLoS ONE"},{"issue":"48","key":"10.1016\/j.vaccine.2015.07.082_bib0305","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1016\/j.vaccine.2012.09.018","article-title":"The role of nasal IgA in children vaccinated with live attenuated influenza vaccine","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.082_bib0310","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/cid\/cit057","article-title":"Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women","volume":"56","author":"Abzug","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.082_bib0315","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.082_bib0320","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T13:24:53Z","timestamp":1537449893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15010609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":32,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15010609"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}